MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 259 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is 0.47 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,121 | – | 4 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tao Capital Management LP | 77,657 | $18,814 | 14.97% |
| Ally Bridge Group (NY) LLC | 29,614 | $7,174,288 | 9.40% |
| Affinity Asset Advisors, LLC | 93,000 | $22,530,180 | 7.44% |
| TCG Crossover Management, LLC | 149,917 | $36,318,892 | 7.08% |
| Avoro Capital Advisors LLC | 1,666,666 | $403,766,505 | 5.99% |
| Perceptive Advisors | 650,562 | $157,605,150 | 4.65% |
| MPM BioImpact LLC | 36,038 | $8,730,566 | 2.27% |
| Nicholas Investment Partners, LP | 117,047 | $28,355,806 | 2.16% |
| Ghost Tree Capital, LLC | 30,000 | $7,268,000 | 2.15% |
| Baker Brothers Advisors | 1,545,113 | $374,319,075 | 2.04% |